NADPH oxidases and angiotensin II receptor signaling

Molecular and Cellular Endocrinology

Volumn 302, Issue 2, 2009, Pages 148-158

  Garrido, Abel Martin ^a   Griendling, Kathy K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Brain; Kidney; NADPH oxidases; Reactive oxygen species; Vascular

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; MYOSIN LIGHT CHAIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA;

CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; ENDOTHELIAL DYSFUNCTION; GENETIC MANIPULATION; HUMAN; HYPERTENSION; KIDNEY; MUSCLE FIBER CONTRACTION; MUSCLE HYPERTROPHY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

BRAIN; CARDIOVASCULAR DISEASES; HUMANS; KIDNEY; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; RECEPTORS, ANGIOTENSIN; SIGNAL TRANSDUCTION;

EID: 62949101948     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.11.003     Document Type: Review

References (168)

1. Agerer F., Lux S., Michel A., Rohde M., Ohlsen K., and Hauck C.R. Cellular invasion by Staphylococcus aureus reveals a functional link between focal adhesion kinase and cortactin in integrin-mediated internalisation. J. Cell Sci. 118 (2005) 2189-2200
2. Ambasta R.K., Schreiber J.G., Janiszewski M., Busse R., and Brandes R.P. Noxa1 is a central component of the smooth muscle NADPH oxidase in mice. Free Radic. Biol. Med. 41 (2006) 193-201
3. Ardaillou R., Chansel D., Chatziantoniou C., and Dussaule J.C. Mesangial AT1 receptors: expression, signaling, and regulation. J. Am. Soc. Nephrol. 10 Suppl. 11 (1999) S40-S46
4. Banfi B., Clark R.A., Steger K., and Krause K.H. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J. Biol. Chem. 278 (2003) 3510-3513
5. Barlow R.S., and White R.E. Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity. Am. J. Physiol. 275 (1998) H1283-H1289
6. Bedard K., and Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87 (2007) 245-313
7. Bendall J.K., Cave A.C., Heymes C., Gall N., and Shah A.M. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105 (2002) 293-296
8. Block K., Ricono J.M., Lee D.Y., Bhandari B., Choudhury G.G., Abboud H.E., and Gorin Y. Arachidonic acid-dependent activation of a p22(phox)-based NAD(P)H oxidase mediates angiotensin II-induced mesangial cell protein synthesis and fibronectin expression via Akt/PKB. Antioxid. Redox Signal. 8 (2006) 1497-1508
9. Block K., Assaad E., Griendling K.K., Lee D.Y., Wittrant Y., and Gorin Y. Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II. Role in mesangial cell hypertrophy and fibronectin expression. J. Biol. Chem. 283 (2008) 24061-24076
10. Browatzki M., Larsen D., Pfeiffer C.A., Gehrke S.G., Schmidt J., Kranzhofer A., Katus H.A., and Kranzhofer R. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner. J. Vasc. Res. 42 (2005) 415-423
11. Burke T.M., and Wolin M.S. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am. J. Physiol. 252 (1987) H721-H732
12. Burke-Wolin T., Abate C.J., Wolin M.S., and Gurtner G.H. Hydrogen peroxide-induced pulmonary vasodilation: role of guanosine 3′,5′-cyclic monophosphate. Am. J. Physiol. 261 (1991) L393-L398
13. Capers Q.t., Alexander R.W., Lou P., De Leon H., Wilcox J.N., Ishizaka N., Howard A.B., and Taylor W.R. Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 30 (1997) 1397-1402
14. 2. J. Biol. Chem. 273 (1998) 32554-32560
15. Chabrashvili T., Kitiyakara C., Blau J., Karber A., Aslam S., Welch W.J., and Wilcox C.S. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am. J. Physiol. Regulat. Integr. Comput. Physiol. 285 (2003) R117-R124
16. Chan S.H., Hsu K.S., Huang C.C., Wang L.L., Ou C.C., and Chan J.Y. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ. Res. 97 (2005) 772-780
17. Chen Z.J., Parent L., and Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 84 (1996) 853-862
18. Chen X.L., Tummala P.E., Olbrych M.T., Alexander R.W., and Medford R.M. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ. Res. 83 (1998) 952-959
19. Cheng T.H., Cheng P.Y., Shih N.L., Chen I.B., Wang D.L., and Chen J.J. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J. Am. Coll. Cardiol. 42 (2003) 1845-1854
20. Cheng G., Diebold B.A., Hughes Y., and Lambeth J.D. Nox1-dependent reactive oxygen generation is regulated by Rac1. J. Biol. Chem. 281 (2006) 17718-17726
21. Choi H., Leto T.L., Hunyady L., Catt K.J., Bae Y.S., and Rhee S.G. Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase. J. Biol. Chem. 283 (2008) 255-267
22. DiDonato J.A., Mercurio F., and Karin M. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol. Cell Biol. 15 (1995) 1302-1311
23. DiDonato J., Mercurio F., Rosette C., Wu-Li J., Suyang H., Ghosh S., and Karin M. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell Biol. 16 (1996) 1295-1304
24. Dikalova A., Clempus R., Lassegue B., Cheng G., McCoy J., Dikalov S., San Martin A., Lyle A., Weber D.S., Weiss D., Taylor W.R., Schmidt H.H., Owens G.K., Lambeth J.D., and Griendling K.K. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112 (2005) 2668-2676
25. Ding G., Zhang A., Huang S., Pan X., Zhen G., Chen R., and Yang T. ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR. Am. J. Physiol. Renal Physiol. 293 (2007) F1889-F1897
26. Doughan A.K., Harrison D.G., and Dikalov S.I. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 102 (2008) 488-496
27. Drummond G.R., Cai H., Davis M.E., Ramasamy S., and Harrison D.G. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ. Res. 86 (2000) 347-354
28. Frank G.D., Eguchi S., Yamakawa T., Tanaka S., Inagami T., and Motley E.D. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. Endocrinology 141 (2000) 3120-3126
29. Fukui T., Ishizaka N., Rajagopalan S., Laursen J.B., Capers Q.t., Taylor W.R., Harrison D.G., de Leon H., Wilcox J.N., and Griendling K.K. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ. Res. 80 (1997) 45-51
30. Funakoshi Y., Ichiki T., Takeda K., Tokuno T., Iino N., and Takeshita A. Critical role of cAMP-response element-binding protein for angiotensin II-induced hypertrophy of vascular smooth muscle cells. J. Biol. Chem. 277 (2002) 18710-18717
31. Gaborik Z., Szaszak M., Szidonya L., Balla B., Paku S., Catt K.J., Clark A.J., and Hunyady L. Beta-arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor. Mol. Pharmacol. 59 (2001) 239-247
32. Gao L., Wang W., Li Y.L., Schultz H.D., Liu D., Cornish K.G., and Zucker I.H. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ. Res. 95 (2004) 937-944
33. Gao L., Wang W., Li Y.L., Schultz H.D., Liu D., Cornish K.G., and Zucker I.H. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H2271-H2279
34. Gardner P.R., Nguyen D.D., and White C.W. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 12248-12252
35. Gavazzi G., Banfi B., Deffert C., Fiette L., Schappi M., Herrmann F., and Krause K.H. Decreased blood pressure in NOX1-deficient mice. FEBS Lett. 580 (2006) 497-504
36. Geiszt M., Kopp J.B., Varnai P., and Leto T.L. Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 8010-8014
37. Geiszt M., Lekstrom K., Witta J., and Leto T.L. Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J. Biol. Chem. 278 (2003) 20006-20012
38. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl. (2002) S81-S96
39. Gongora M.C., Qin Z., Laude K., Kim H.W., McCann L., Folz J.R., Dikalov S., Fukai T., and Harrison D.G. Role of extracellular superoxide dismutase in hypertension. Hypertension 48 (2006) 473-481
40. Gorin Y., Kim N.H., Feliers D., Bhandari B., Choudhury G.G., and Abboud H.E. Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase. Faseb J. 15 (2001) 1909-1920
41. Gorin Y., Ricono J.M., Kim N.H., Bhandari B., Choudhury G.G., and Abboud H.E. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am. J. Physiol. Renal Physiol. 285 (2003) F219-F229
42. Gorin Y., Ricono J.M., Wagner B., Kim N.H., Bhandari B., Choudhury G.G., and Abboud H.E. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. Biochem. J. 381 (2004) 231-239
43. Gorlach A., Diebold I., Schini-Kerth V.B., Berchner-Pfannschmidt U., Roth U., Brandes R.P., Kietzmann T., and Busse R. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ. Res. 89 (2001) 47-54
44. Griendling K.K., Rittenhouse S.E., Brock T.A., Ekstein L.S., Gimbrone Jr. M.A., and Alexander R.W. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J. Biol. Chem. 261 (1986) 5901-5906
45. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74 (1994) 1141-1148
46. Hannken T., Schroeder R., Stahl R.A., and Wolf G. Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. Kidney Int. 54 (1998) 1923-1933
47. Haque M.Z., and Majid D.S. Assessment of renal functional phenotype in mice lacking gp91PHOX subunit of NAD(P)H oxidase. Hypertension 43 (2004) 335-340
48. Hassanain H.H., Gregg D., Marcelo M.L., Zweier J.L., Souza H.P., Selvakumar B., Ma Q., Moustafa-Bayoumi M., Binkley P.F., Flavahan N.A., Morris M., Dong C., and Goldschmidt-Clermont P.J. Hypertension caused by transgenic overexpression of Rac1. Antioxid. Redox Signal. 9 (2007) 91-100
49. Heeneman S., Haendeler J., Saito Y., Ishida M., and Berk B.C. Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc. J. Biol. Chem. 275 (2000) 15926-15932
50. Heitzer T., Wenzel U., Hink U., Krollner D., Skatchkov M., Stahl R.A., MacHarzina R., Brasen J.H., Meinertz T., and Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int. 55 (1999) 252-260
51. Higashi M., Shimokawa H., Hattori T., Hiroki J., Mukai Y., Morikawa K., Ichiki T., Takahashi S., and Takeshita A. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ. Res. 93 (2003) 767-775
52. Hilenski L.L., Clempus R.E., Quinn M.T., Lambeth J.D., and Griendling K.K. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 677-683
53. Hilgers R.H., Todd Jr. J., and Webb R.C. Increased PDZ-RhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II-induced hypertensive rats. J. Hypertens. 25 (2007) 1687-1697
54. Hingtgen S.D., Tian X., Yang J., Dunlay S.M., Peek A.S., Wu Y., Sharma R.V., Engelhardt J.F., and Davisson R.L. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol. Genom. 26 (2006) 180-191
55. Hordijk P.L. Regulation of NADPH oxidases: the role of Rac proteins. Circ. Res. 98 (2006) 453-462
56. Hsieh C.C., and Papaconstantinou J. Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice. Faseb J. 20 (2006) 259-268
57. Ichiki T., Tokunou T., Fukuyama K., Iino N., Masuda S., and Takeshita A. Cyclic AMP response element-binding protein mediates reactive oxygen species-induced c-fos expression. Hypertension 42 (2003) 177-183
58. Ishizaka N., Griendling K.K., Lassegue B., and Alexander R.W. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32 (1998) 459-466
59. Jaimes E.A., Galceran J.M., and Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int. 54 (1998) 775-784
60. Jaimes E.A., Tian R.X., Pearse D., and Raij L. Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int. 68 (2005) 2143-2153
61. Jaimes E.A., Zhou M.S., Pearse D.D., Puzis L., and Raij L. Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species. Am. J. Physiol. Renal Physiol. 294 (2008) F385-F392
62. 2-induced contraction in pulmonary artery. Am. J. Physiol. 272 (1997) H2686-H2692
63. Juarez J.C., Manuia M., Burnett M.E., Betancourt O., Boivin B., Shaw D.E., Tonks N.K., Mazar A.P., and Donate F. Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 7147-7152
64. Karathanassis D., Stahelin R.V., Bravo J., Perisic O., Pacold C.M., Cho W., and Williams R.L. Binding of the PX domain of p47(phox) to phosphatidylinositol 3,4-bisphosphate and phosphatidic acid is masked by an intramolecular interaction. Embo J. 21 (2002) 5057-5068
65. Kopkan L., Castillo A., Navar L.G., and Majid D.S. Enhanced superoxide generation modulates renal function in ANG II-induced hypertensive rats. Am. J. Physiol. Renal Physiol. 290 (2006) F80-F86
66. Kwon J., Lee S.R., Yang K.S., Ahn Y., Kim Y.J., Stadtman E.R., and Rhee S.G. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 16419-16424
67. Kyaw M., Yoshizumi M., Tsuchiya K., Kirima K., and Tamaki T. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens. Res. 24 (2001) 251-261
68. Landmesser U., Cai H., Dikalov S., McCann L., Hwang J., Jo H., Holland S.M., and Harrison D.G. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40 (2002) 511-515
69. Lassegue B., Sorescu D., Szocs K., Yin Q., Akers M., Zhang Y., Grant S.L., Lambeth J.D., and Griendling K.K. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88 (2001) 888-894
70. Laude K., Cai H., Fink B., Hoch N., Weber D.S., McCann L., Kojda G., Fukai T., Schmidt H.H., Dikalov S., Ramasamy S., Gamez G., Griendling K.K., and Harrison D.G. Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H7-H12
71. Lavigne M.C., Malech H.L., Holland S.M., and Leto T.L. Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 104 (2001) 79-84
72. 2. J. Biol. Chem. 277 (2002) 20336-20342
73. Leslie N.R., Bennett D., Lindsay Y.E., Stewart H., Gray A., and Downes C.P. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. Embo J. 22 (2003) 5501-5510
74. Liu Y., and Gutterman D.D. Oxidative stress and potassium channel function. Clin. Exp. Pharmacol. Physiol. 29 (2002) 305-311
75. Liu J., Yang F., Yang X.P., Jankowski M., and Pagano P.J. NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 776-782
76. Lodha S., Dani D., Mehta R., Bhaskaran M., Reddy K., Ding G., and Singhal P.C. Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress. Mol. Med. 8 (2002) 830-840
77. Lopez B., Salom M.G., Arregui B., Valero F., and Fenoy F.J. Role of superoxide in modulating the renal effects of angiotensin II. Hypertension 42 (2003) 1150-1156
78. Mahadev K., Motoshima H., Wu X., Ruddy J.M., Arnold R.S., Cheng G., Lambeth J.D., and Goldstein B.J. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell Biol. 24 (2004) 1844-1854
79. Manea A., Manea S.A., Gafencu A.V., Raicu M., and Simionescu M. AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 878-885
80. Martyn K.D., Frederick L.M., von Loehneysen K., Dinauer M.C., and Knaus U.G. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal. 18 (2006) 69-82
81. Matsuno K., Yamada H., Iwata K., Jin D., Katsuyama M., Matsuki M., Takai S., Yamanishi K., Miyazaki M., Matsubara H., and Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112 (2005) 2677-2685
82. Matsuzawa A., Saegusa K., Noguchi T., Sadamitsu C., Nishitoh H., Nagai S., Koyasu S., Matsumoto K., Takeda K., and Ichijo H. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 6 (2005) 587-592
83. Miller A.A., Drummond G.R., and Sobey C.G. Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacol. Ther. 111 (2006) 928-948
84. Miller Jr. F.J., Filali M., Huss G.J., Stanic B., Chamseddine A., Barna T.J., and Lamb F.S. Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ. Res. 101 (2007) 663-671
85. Miura H., Bosnjak J.J., Ning G., Saito T., Miura M., and Gutterman D.D. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ. Res. 92 (2003) e31-40
86. Miyano K., Ueno N., Takeya R., and Sumimoto H. Direct involvement of the small GTPase Rac in activation of the superoxide-producing NADPH oxidase Nox1. J. Biol. Chem. 281 (2006) 21857-21868
87. Modlinger P., Chabrashvili T., Gill P.S., Mendonca M., Harrison D.G., Griendling K.K., Li M., Raggio J., Wellstein A., Chen Y., Welch W.J., and Wilcox C.S. RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension 47 (2006) 238-244
88. Mollnau H., Wendt M., Szocs K., Lassegue B., Schulz E., Oelze M., Li H., Bodenschatz M., August M., Kleschyov A.L., Tsilimingas N., Walter U., Forstermann U., Meinertz T., Griendling K., and Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90 (2002) E58-65
89. Monteiro H.P., Arai R.J., and Travassos L.R. Protein tyrosine phosphorylation and protein tyrosine nitration in redox signaling. Antioxid. Redox Signal. 10 (2008) 843-889
90. Mori T., and Cowley Jr. A.W. Angiotensin II-NAD(P)H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension 42 (2003) 588-593
91. Mori T., O'Connor P.M., Abe M., and Cowley Jr. A.W. Enhanced superoxide production in renal outer medulla of Dahl salt-sensitive rats reduces nitric oxide tubular-vascular cross-talk. Hypertension 49 (2007) 1336-1341
92. Moriguchi Y., Matsubara H., Mori Y., Murasawa S., Masaki H., Maruyama K., Tsutsumi Y., Shibasaki Y., Tanaka Y., Nakajima T., Oda K., and Iwasaka T. Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms. Circ. Res. 84 (1999) 1073-1084
93. Mumbengegwi D.R., Li Q., Li C., Bear C.E., and Engelhardt J.F. Evidence for a superoxide permeability pathway in endosomal membranes. Mol. Cell Biol. 28 (2008) 3700-3712
94. Ni W., Zhan Y., He H., Maynard E., Balschi J.A., and Oettgen P. Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin II. Circ. Res. 101 (2007) 985-994
95. Nickenig G., Baudler S., Muller C., Werner C., Werner N., Welzel H., Strehlow K., and Bohm M. Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo. Faseb J. 16 (2002) 1077-1086
96. Nouri P., Gill P., Li M., Wilcox C.S., and Welch W.J. p22phox in the macula densa regulates single nephron GFR during angiotensin II infusion in rats. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1685-H1689
97. Ortego M., Bustos C., Hernandez-Presa M.A., Tunon J., Diaz C., Hernandez G., and Egido J. Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 147 (1999) 253-261
98. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., and Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 14483-14488
99. Pearse D.D., Tian R.X., Nigro J., Iorgulescu J.B., Puzis L., and Jaimes E.A. Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells. Am. J. Physiol. Renal Physiol. 294 (2008) F1094-F1100
100. Phillips M.I. Functions of angiotensin in the central nervous system. Annu. Rev. Physiol. 49 (1987) 413-435
101. Pinzar E., Wang T., Garrido M.R., Xu W., Levy P., and Bottari S.P. Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells. FEBS Lett. 579 (2005) 5100-5104
102. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., and Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97 (1996) 1916-1923
103. 2+ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms. Biochem. Pharmacol. 67 (2004) 491-502
104. Rodriguez-Puyol M., Griera-Merino M., Perez-Rivero G., Diez-Marques M.L., Ruiz-Torres M.P., and Rodriguez-Puyol D. Angiotensin II induces a rapid and transient increase of reactive oxygen species. Antioxid. Redox Signal. 4 (2002) 869-875
105. Salmeen A., and Barford D. Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antioxid. Redox Signal. 7 (2005) 560-577
106. Sangrar W., Gao Y., Scott M., Truesdell P., and Greer P.A. Fer-mediated cortactin phosphorylation is associated with efficient fibroblast migration and is dependent on reactive oxygen species generation during integrin-mediated cell adhesion. Mol. Cell Biol. 27 (2007) 6140-6152
107. Sano M., Fukuda K., Sato T., Kawaguchi H., Suematsu M., Matsuda S., Koyasu S., Matsui H., Yamauchi-Takihara K., Harada M., Saito Y., and Ogawa S. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ. Res. 89 (2001) 661-669
108. Sato A., Sakuma I., and Gutterman D.D. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H2345-H2354
109. Satoh M., Ogita H., Takeshita K., Mukai Y., Kwiatkowski D.J., and Liao J.K. Requirement of Rac1 in the development of cardiac hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 7432-7437
110. Savitsky P.A., and Finkel T. Redox regulation of Cdc25C. J. Biol. Chem. 277 (2002) 20535-20540
111. Schlaich M.P., Parnell M.M., Ahlers B.A., Finch S., Marshall T., Zhang W.Z., and Kaye D.M. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects. Circulation 110 (2004) 3680-3686
112. Seko T., Ito M., Kureishi Y., Okamoto R., Moriki N., Onishi K., Isaka N., Hartshorne D.J., and Nakano T. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ. Res. 92 (2003) 411-418
113. Seshiah P.N., Weber D.S., Rocic P., Valppu L., Taniyama Y., and Griendling K.K. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ. Res. 91 (2002) 406-413
114. Shang L.L., Sanyal S., Pfahnl A.E., Jiao Z., Allen J., Liu H., and Dudley Jr. S.C. NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. Am. J. Physiol. Cell Physiol. 294 (2008) C372-C379
115. Somlyo A.P., and Somlyo A.V. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J. Physiol. 522 Pt 2 (2000) 177-185
116. Sumimoto H. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. Febs J. 275 (2008) 3249-3277
117. Sun C., Sellers K.W., Sumners C., and Raizada M.K. NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circ. Res. 96 (2005) 659-666
118. Tabet F., Savoia C., Schiffrin E.L., and Touyz R.M. Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 44 (2004) 200-208
119. Tabet F., Schiffrin E.L., Callera G., He Y., Yao G., Ostman A., Kappert K., Tonks N.K., and Touyz R.M. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR. Circ. Res. (2008) Epub Jun 19
120. Taddei S., Virdis A., Mattei P., Ghiadoni L., Sudano I., and Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 94 (1996) 1298-1303
121. Takeya R., Ueno N., Kami K., Taura M., Kohjima M., Izaki T., Nunoi H., and Sumimoto H. Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J. Biol. Chem. 278 (2003) 25234-25246
122. Taniyama Y., Ushio-Fukai M., Hitomi H., Rocic P., Kingsley M.J., Pfahnl C., Weber D.S., Alexander R.W., and Griendling K.K. Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 287 (2004) C494-C499
123. Tonks N.K. Redox redux: revisiting PTPs and the control of cell signaling. Cell 121 (2005) 667-670
124. Torrecillas G., Boyano-Adanez M.C., Medina J., Parra T., Griera M., Lopez-Ongil S., Arilla E., Rodriguez-Puyol M., and Rodriguez-Puyol D. The role of hydrogen peroxide in the contractile response to angiotensin II. Mol. Pharmacol. 59 (2001) 104-112
125. Touyz R.M., and Schiffrin E.L. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 34 (1999) 976-982
126. Touyz R.M., He G., Deng L.Y., and Schiffrin E.L. Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries. Circulation 99 (1999) 392-399
127. 2+ signaling by angiotensin II in human vascular smooth muscle cells. J. Hypertens. 19 (2001) 441-449
128. Touyz R.M., Chen X., Tabet F., Yao G., He G., Quinn M.T., Pagano P.J., and Schiffrin E.L. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ. Res. 90 (2002) 1205-1213
129. Touyz R.M., Cruzado M., Tabet F., Yao G., Salomon S., and Schiffrin E.L. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Can. J. Physiol. Pharmacol. 81 (2003) 159-167
130. Touyz R.M., Yao G., and Schiffrin E.L. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 981-987
131. Touyz R.M., Yao G., Viel E., Amiri F., and Schiffrin E.L. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J. Hypertens. 22 (2004) 1141-1149
132. Touyz R.M., Mercure C., He Y., Javeshghani D., Yao G., Callera G.E., Yogi A., Lochard N., and Reudelhuber T.L. Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase. Hypertension 45 (2005) 530-537
133. Tsai C.T., Wang D.L., Chen W.P., Hwang J.J., Hsieh C.S., Hsu K.L., Tseng C.D., Lai L.P., Tseng Y.Z., Chiang F.T., and Lin J.L. Angiotensin II increases expression of alpha1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes. Circ. Res. 100 (2007) 1476-1485
134. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T., Tamakawa H., Yamagami K., Inui J., Maekawa M., and Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389 (1997) 990-994
135. Ueyama T., Geiszt M., and Leto T.L. Involvement of Rac1 in activation of multicomponent Nox1- and Nox3-based NADPH oxidases. Mol. Cell Biol. 26 (2006) 2160-2174
136. Ueyama T., Lekstrom K., Tsujibe S., Saito N., and Leto T.L. Subcellular localization and function of alternatively spliced Noxo1 isoforms. Free Radic. Biol. Med. 42 (2007) 180-190
137. Ushio-Fukai M., Alexander R.W., Akers M., Yin Q., Fujio Y., Walsh K., and Griendling K.K. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J. Biol. Chem. 274 (1999) 22699-22704
138. Ushio-Fukai M., Griendling K.K., Becker P.L., Hilenski L., Halleran S., and Alexander R.W. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 489-495
139. Ushio-Fukai M., Hilenski L., Santanam N., Becker P.L., Ma Y., Griendling K.K., and Alexander R.W. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J. Biol. Chem. 276 (2001) 48269-48275
140. Viedt C., Soto U., Krieger-Brauer H.I., Fei J., Elsing C., Kubler W., and Kreuzer J. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 940-948
141. Viedt C., Fei J., Krieger-Brauer H.I., Brandes R.P., Teupser D., Kamimura M., Katus H.A., and Kreuzer J. Role of p22phox in angiotensin II and platelet-derived growth factor AA induced activator protein 1 activation in vascular smooth muscle cells. J. Mol. Med. 82 (2004) 31-38
142. Wang H.D., Xu S., Johns D.G., Du Y., Quinn M.T., Cayatte A.J., and Cohen R.A. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ. Res. 88 (2001) 947-953
143. Wang D., Chen Y., Chabrashvili T., Aslam S., Borrego Conde L.J., Umans J.G., and Wilcox C.S. Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. J. Am. Soc. Nephrol. 14 (2003) 2783-2789
144. 2+, and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius. Hypertension 48 (2006) 482-489
145. Weber D.S., Rocic P., Mellis A.M., Laude K., Lyle A.N., Harrison D.G., and Griendling K.K. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H37-H42
146. Wei E.P., Kontos H.A., and Beckman J.S. Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite. Am. J. Physiol. 271 (1996) H1262-H1266
147. Welch W.J., Blau J., Xie H., Chabrashvili T., and Wilcox C.S. Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H22-H28
148. Wenzel S., Taimor G., Piper H.M., and Schluter K.D. Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes. Faseb J. 15 (2001) 2291-2293
149. Wilson S.K. Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rat. Circ. Res. 66 (1990) 722-734
150. Wingler K., Wunsch S., Kreutz R., Rothermund L., Paul M., and Schmidt H.H. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic. Biol. Med. 31 (2001) 1456-1464
151. Wu S., Gao J., Ohlemeyer C., Roos D., Niessen H., Kottgen E., and Gessner R. Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes. Free Radic. Biol. Med. 39 (2005) 1601-1610
152. Yang Z.W., Zheng T., Zhang A., Altura B.T., and Altura B.M. Mechanisms of hydrogen peroxide-induced contraction of rat aorta. Eur. J. Pharmacol. 344 (1998) 169-181
153. 2+]i in canine cerebral arterial smooth muscle: participation of cellular signaling pathways. Naunyn Schmiedebergs Arch. Pharmacol. 360 (1999) 646-653
154. Yang H., Shi M., VanRemmen H., Chen X., Vijg J., Richardson A., and Guo Z. Reduction of pressor response to vasoconstrictor agents by overexpression of catalase in mice. Am. J. Hypertens. 16 (2003) 1-5
155. Yang Z., Venardos K., Jones E., Morris B.J., Chin-Dusting J., and Kaye D.M. Identification of a novel polymorphism in the 3'UTR of the L-arginine transporter gene SLC7A1: contribution to hypertension and endothelial dysfunction. Circulation 115 (2007) 1269-1274
156. Ying Z., Jin L., Palmer T., and Webb R.C. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells. Mol. Pharmacol. 69 (2006) 932-940
157. Yogi A., Mercure C., Touyz J., Callera G.E., Montezano A.C., Aranha A.B., Tostes R.C., Reudelhuber T., and Touyz R.M. Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension 51 (2008) 500-506
158. Yoshizumi M., Tsuchiya K., Kirima K., Kyaw M., Suzaki Y., and Tamaki T. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol. Pharmacol. 60 (2001) 656-665
159. Yu H.Y., Inoguchi T., Nakayama M., Tsubouchi H., Sato N., Sonoda N., Sasaki S., Kobayashi K., and Nawata H. Statin attenuates high glucose-induced and angiotensin II-induced MAP kinase activity through inhibition of NAD(P)H oxidase activity in cultured mesangial cells. Med. Chem. 1 (2005) 461-466
160. Zafari A.M., Ushio-Fukai M., Minieri C.A., Akers M., Lassegue B., and Griendling K.K. Arachidonic acid metabolites mediate angiotensin II-induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells. Antioxid. Redox Signal. 1 (1999) 167-179
161. Zhan Y., Brown C., Maynard E., Anshelevich A., Ni W., Ho I.C., and Oettgen P. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J. Clin. Invest. 115 (2005) 2508-2516
162. Zhang C., Kavurma M.M., Lai A., and Khachigian L.M. Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1: ETS-1 regulates basal and and inducible p21WAF1/Cip: ETS-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements in the p21WAF/Cip1 promoter. J. Biol. Chem. 278 (2003) 27903-27909
163. Zhao W., Chen S.S., Chen Y., Ahokas R.A., and Sun Y. Kidney fibrosis in hypertensive rats: role of oxidative stress. Am. J. Nephrol. 28 (2008) 548-554
164. Zimmerman M.C., Lazartigues E., Lang J.A., Sinnayah P., Ahmad I.M., Spitz D.R., and Davisson R.L. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ. Res. 91 (2002) 1038-1045
165. Zimmerman M.C., Dunlay R.P., Lazartigues E., Zhang Y., Sharma R.V., Engelhardt J.F., and Davisson R.L. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ. Res. 95 (2004) 532-539
166. Zimmerman M.C., Lazartigues E., Sharma R.V., and Davisson R.L. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ. Res. 95 (2004) 210-216
167. Zimmerman M.C., Sharma R.V., and Davisson R.L. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 45 (2005) 717-723
168. Zuo L., Ushio-Fukai M., Ikeda S., Hilenski L., Patrushev N., and Alexander R.W. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1824-1830